(2R,3R,4S,5R,6R)-2-(Allyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 95.0%, 1g

Nifedipine, 98.0%, 5g

tert-butyl (2S)-2-[4-(3-bromophenyl)-1H-imidazol-2-yl]pyrrolidine-1-carboxylate, 95%, 1g

4-[3-(4-methoxyphenyl)-6-oxopyridazin-1(6H)-yl]butanoic acid, 95.0%, 250mg

N'-Naphthalen-2-ylacetohydrazide, 95+%, 500mg

2-(3-(Chloromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

2-Methylcyclohexylamine (cis- and trans- mixture)>95.0%(GC)(T)500mL

4-(Trifluoromethyl)phenylacetic acid, 97.0%, 5g

2-(3H-[1,2,3]Triazolo[4,5-b]pyridin-3-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate, 95.0%, 5g

2,2-DIMETHYLTETRAHYDRO-2H-PYRAN-4-OL, 95.0%, 100mg

3-Acetyl-2,6-difluorobenzoic acid, 98%, 100g

1-(2,6-Diethylphenyl)-2,2,4-trimethyl-4-phenyl-3,4-dihydro-2H-pyrrol-1-ium Tetrafluoroborate>98.0%(HPLC)1g

2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 97.0%, 1g